Ether à go-go potassium channels and cancer

Javier Camacho1

  • 1Pharmacology Section, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Avenida Instituto Politécnico Nacional 2508, México, DF 07360, México. fcamacho@cinvestav.mx

Cancer Letters
|February 14, 2006
PubMed

Insights

Ether à go-go (EAG) potassium channels are increasingly important in cancer research. This review explores their role in cancer detection and therapy, focusing on expression, oncogenic properties, and cellular mechanisms.

Area of Science:

  • Molecular Biology
  • Oncology
  • Ion Channel Physiology

Background:

  • Ion channels are crucial for cellular functions and implicated in various diseases.
  • A growing body of evidence links potassium channels, particularly EAG family members, to cancer development and progression.

Purpose of the Study:

  • To review current findings on the relationship between ether à go-go (EAG) potassium channels and cancer.
  • To focus on EAG channel mRNA expression, oncogenic properties, and pharmacological modulation in the context of cancer.

Main Methods:

  • Literature review of studies investigating EAG channels in cancer.
  • Analysis of research on EAG channel mRNA expression in cancerous tissues.
  • Examination of studies detailing the oncogenic properties and cellular mechanisms of EAG channels.

Main Results:

  • Ether à go-go (EAG) potassium channels are frequently dysregulated in various cancers.
  • EAG channels exhibit oncogenic properties, influencing cell proliferation, migration, and survival.
  • Modulation and pharmacology of EAG channels present potential therapeutic strategies for cancer treatment.

Conclusions:

  • Ether à go-go (EAG) potassium channels represent promising targets for cancer detection and therapy.
  • Further research into the cellular mechanisms of EAG oncogenicity is warranted to develop effective treatments.

Related Concept Videos

Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...